朗姿股份：子公司朗姿医管通过员工持股平台实施医美业务激励

Core Viewpoint - The company is accelerating its national layout in the medical beauty business and establishing a long-term incentive mechanism through investments in new or existing medical beauty institutions by its wholly-owned subsidiary, Langzi Medical Management Group [2] Group 1: Business Strategy - Langzi Medical Management Group is collaborating with management and key employees in the medical beauty sector to invest in new medical beauty institutions [2] - The transaction aims to enhance the motivation of key employees and improve the operational performance of the subsidiary, constituting a related party transaction [2] Group 2: Financial Performance - For the first three quarters of 2025, the company achieved total operating revenue of 4.328 billion yuan, representing a year-on-year increase of 0.89% [2] - The net profit attributable to the parent company reached 989 million yuan, showing a significant year-on-year growth of 366.95% [2] Group 3: Risk Management - The company asserts that the arrangement is controllable in terms of risk and will not have a significant adverse impact on its financial and operational status [2] - There are no circumstances that would harm the rights and interests of the listed company and minority shareholders [2] - The company will follow approval and information disclosure procedures for any future related party transactions to ensure fair pricing [2]